Top Tech Companies (764)
Don't see your company?
Create a company profile
Regulonix is a biotechnology company that develops non-opioid drugs for chronic pain.
Demegen is a Pharmaceutical Company.
At Endo, our far-reaching vision is simple: to help everyone we serve live their best life. As a specialty pharmaceutical company, we’re motivated by a strong sense of purpose to find better ways to meet unique medical needs. Our global team of passionate employees understands the importance of their work. We’re dedicated to supporting one another as we connect with communities and foster partnerships that elevate quality-of-life and bring the best treatments forward. Our uncompromising commitment results in the delivery of life-enhancing therapies. From intelligent product selection to commercialization, we strive to make a meaningful, tangible impact to help everyone live their best life. Endo has global headquarters in Malvern, Pennsylvania. Community Guidelines: 1. Be respectful. Everyone who visits our page should feel comfortable and respected. 2. If we see a comment that violates anything in the following list, it may be removed. • Comments that use profanity; personally attack or bully another individual; or are off-topic, misleading, factually inaccurate, political, spam, defamatory, discriminatory or promotional. • Comments that are excessively repetitive and/or disruptive to the community. • Comments that promote illegal activity, use copyrights or trademarks or are related to an ongoing legal matter. • Comments that appear to be medical advice. We reserve the right to remove a reply for any reason at any time. 3. Adverse Event Reporting: If we see a post about an adverse event, an Endo representative will need to contact you to find out more information to comply with regulatory guidelines. If you experience a side effect while using an Endo product, please consult your physician or pharmacist immediately. You may also report to the FDA at fda.gov/medwatch or 800-FDA-1088. Replies from other users do not necessarily reflect the views of Endo. We do not endorse content added by other users.
Tioga Pharmaceuticals develops therapies for the treatment of gastrointestinal diseases.
Secura Bio™ is a pharmaceutical company committed to giving patients access to innovative therapies.
Chase Therapeutics is an early-stage, product-based specialty pharmaceutical company
We are located near the Texas Medical Center in Houston, Texas. Under the leadership of Alice S. Weissfeld, Ph.D., D (ABMM), and Paula H. Vance, SM(NRM), SM(ASCP), CLS(M), msi has remained in the forefront of microbiology testing since 1984 and maintains a reputation for scientifically reliable testing. Originally founded as a clinical microbiology reference laboratory, msi subsequently expanded its services to include environmental microbiology and pharmaceutical and diagnostic trials. MSI has built a strong reputation as a central microbiology lab. Our heritage of scientific and therapeutic excellence translates to the highest standards for our sponsors. Dr. Weissfeld reviews all testing methods and schema to ensure the most efficient and effective study design. We routinely add new tests and evaluate industry trends in order to build our capabilities to support client needs. We offer scientific expertise related to: Protocol consultation Veterinarian Clinical Trials Medical Device Pharmaceutical Please contact us today to discuss your Microbiology needs for any type of clinical trial or USP Compliance.
Kronos Bio is a clinical-stage biopharmaceutical company developing therapeutics that target the dysregulated transcription that causes cancer and other serious diseases. Our pipeline includes two investigational oral SYK inhibitors, entospletinib and lanraplenib, which are being developed to treat acute myeloid leukemia (AML). Together the compounds have the potential to target mutations present in more than two-thirds of patients with AML. We are also advancing an oral CDK9 inhibitor, KB-0742, to treat patients with solid tumors addicted to oncogenic transcription factor activity. KB-0742 is the first investigational medicine from our internal discovery platform to enter the clinic. Beyond these three investigational compounds, we are progressing additional discovery programs, including one focused on the MYC TRN and another focused on the AR TRN. For additional information about our community guidelines, visit: https://bit.ly/3FfcDQW.
Evolution Health Group is a full-service healthcare communications agency which has broad strategic capabilities and consists of 3 main divisions, Evolution Medical Communications (with expertise with respect to delivering P2P engagement strategy from pre-launch to LOE), Maestro360 (with expertise in program execution of meetings, events and conventions), BluLava (with expertise with respect to optimizing the customer engagement experience) and Darwin Academy (dedicated to providing novel, interactive peer to peer education). Evolution has proven success in partnering with pharmaceutical customers to launch new products leveraging market insights to drive critical brand planning decisions and maximize outcomes throughout each product’s life cycle. We value creating strong strategic partnerships with our customers by better understanding their challenges and opportunities through ongoing and evolutionary account management best practices. By adhering to the highest possible ethical standards and industry guidelines along with unparalled dedication to our employees and value-added partners, Evolution will work with our customers to help them evolve in order to deliver maximum physician engagement success in the ever-changing pharmaceutical environment. Evolution's focus on innovation has resulted in our creating novel engagement initiatives and proprietary digital offerings that were custom-made with our pharmaceutical clients in mind. Contact us to learn more!
Aurora Pharmaceutical - We are creating the products you want by using innovative, state-of-the-art, environmentally friendly technologies. … Devoted to the development of innovative products •Improved formulations utilizing state-of-the-art ingredient technologies •Committed to taking advantage of sustainable green technologies •Enhanced product performance •Engineered for competitive advantage in the marketplace •Science-based marketing support for our trading partners
.jpeg)
.png)
A devision of ATTWILL Vascular Technologies, Attwill Medical Solutions purchased the assets of Anteco Pharma facility In 2017. Attwill Medical Solutions specializes in the lyophilization and related processing of pharmaceutical intermediates, medical devices and specialty food and nutritional ingredients. ATTWILL operates a fully integrated commercialization business within a 36,500 square foot facility that includes R&D laboratories, piloting facilities and seven ISO 7 cleanrooms for manufacturing. Our ISO 13485 2016 manufacturing includes six freeze dryers that are used in the processing of ATTWILL products and in contract manufacturing of products that include pharmaceuticals, drug ingredients, medical devices, and nutraceuticals
Transomic is a biotechnology startup that provides research tools to accelerate the complexity of life and human disease.
Colorcon® is a world leader in the development, supply and technical support of formulated film coating systems, modified release technologies, and functional excipients for the pharmaceutical and nutritional industries. Our best-in-class products and technologies are complemented by our extensive formulation experience, application data and value-added services to support all phases of solid oral dose design, development and manufacture. Our focus on market issues and technology development has earned Colorcon an international reputation as a pharmaceutical supplier of choice. That reputation is based on superior product quality, unparalleled technical support, extensive regulatory assistance and reliable supply from multiple locations. Colorcon has 22 technical service laboratories globally and more than 1300 employees exclusively dedicated to its customer base. Follow us on Twitter @Colorcon
Longboard Pharmaceuticals, Inc. (Longboard) is a clinical-stage biopharmaceutical company focused on developing novel, transformative medicines for neurological diseases. Longboard was formed in January 2020 by Arena Pharmaceuticals, Inc. (Arena) to advance a portfolio of centrally acting product candidates designed to be highly selective for specific G protein-coupled receptors (GPCRs). Longboard’s small molecule product candidates were discovered out of the same platform at Arena that represents a culmination of more than 20 years of GPCR research. Longboard is evaluating LP352, an oral, centrally acting, 5-hydroxytryptamine 2c receptor subtype superagonist, in development for the potential treatment of developmental and epileptic encephalopathies. Longboard is also evaluating LP659, a centrally acting, sphingosine-1-phosphate receptor subtypes 1 and 5 modulator, in development for the potential treatment of multiple neurological diseases, and LP143, a centrally acting, full cannabinoid type 2 receptor agonist, in development for the potential treatment of CNS diseases and disorders.
Tvardi is a clinical stage, private biotechnology company developing a new class of breakthrough medicines for diverse cancers.
Medelis is a pharmaceutical company located in Nashville.
Pure Nootropics is a developer of smart drugs that enhances people's lives.
Centricity Research is an integrated research organization (IRO) with more than 40 wholly owned and integrated clinical research offices across North America. The company conducts Phase I-IV clinical research in over 35 therapeutic areas: inpatient and outpatient; pharmaceutical, biotechnology, and medical device trials. For more than 25 years, the organization’s founders have worked to revolutionize research by investing in the people and technology needed to deliver outstanding clinical trial experiences, earning numerous awards including “Best Places to Work” and recognition for “Outstanding Diversity in Clinical Research.” Jobseekers: Apply here >> https://centricityresearch.applytojob.com/apply
BioBlocks is a medicinal research organization that provides medicinal chemistry services and products to pharmaceutical customers.
Oragenics develops oral probiotic products and antibiotics for humans and companion pets.
